In April 2016 Manchester eScholar was replaced by the University of Manchesterā€™s new Research Information Management System, Pure. In the autumn the Universityā€™s research outputs will be available to search and browse via a new Research Portal. Until then the Universityā€™s full publication record can be accessed via a temporary portal and the old eScholar content is available to search and browse via this archive.

Update and Mutational Analysis of SLC20A2: A Major Cause of Primary Familial Brain Calcification.

Lemos, Roberta R; Ramos, Eliana M; Legati, Andrea; Nicolas, GaĆ«l; Jenkinson, Emma M; Livingston, John H; Crow, Yanick J; Campion, Dominique; Coppola, Giovanni; Oliveira, JoĆ£o R M

Human mutation. 2015;.

Access to files

Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:

Full-text held externally

Abstract

Primary familial brain calcification (PFBC) is a heterogeneous neuropsychiatric disorder, with affected individuals presenting a wide variety of motor and cognitive impairments, such as migraine, parkinsonism, psychosis, dementia, and mood swings. Calcifications are usually symmetrical, bilateral, and found predominantly in the basal ganglia, thalamus, and cerebellum. So far, variants in three genes have been linked to PFBC: SLC20A2, PDGFRB, and PDGFB. Variants in SLC20A2 are responsible for most cases identified so far and, therefore, the present review is a comprehensive worldwide summary of all reported variants to date. SLC20A2 encodes an inorganic phosphate transporter, PiT-2, widely expressed in various tissues, including brain, and is part of a major family of solute carrier membrane transporters. Fifty variants reported in 55 unrelated patients so far have been identified in families of diverse ethnicities and only few are recurrent. Various types of variants were detected (missense, nonsense, frameshift) including full or partial SLC20A2 deletions. The recently reported SLC20A2 knockout mouse will enhance our understanding of disease mechanism and allow for screening of therapeutic compounds. In the present review, we also discuss the implications of these recent exciting findings and consider the possibility of treatments based on manipulation of inorganic phosphate homeostasis.

Bibliographic metadata

Type of resource:
Content type:
Publication type:
Published date:
Journal title:
Abbreviated journal title:
ISSN:
Digital Object Identifier:
10.1002/humu.22778
Pubmed Identifier:
25726928
Access state:
Active

Institutional metadata

University researcher(s):

Record metadata

Manchester eScholar ID:
uk-ac-man-scw:263156
Created by:
Chase, Diana
Created:
21st April, 2015, 16:46:59
Last modified by:
Chase, Diana
Last modified:
21st April, 2015, 16:46:59

Can we help?

The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.